340binformed.org

Your Free Source for 340B News and Commentary

  • About us
  • Advertise
  • Contact
  • 340B Health

340B Drug Purchases Are Just Shy of $7 Billion Annually

HRSA supplies figure in a filing in orphan drug exclusion lawsuit 

January 9, 2014—The dollar amount of pharmaceuticals purchased through the 340B program has been a guesstimate—until now. … [Read more...]

Hospitals Provided $45.9 Billion in Uncompensated Care in 2012, Study Shows

1 in 3 Americans incur medical debts, mainly due to high cost-sharing plans, separate report finds 

January 8, 2014—U.S. hospitals provided a record-high $45.9 billion in unreimbursed care to indigent and underinsured patients in 2012, an 11.7 percent increase over 2011, according to a new American Hospital Association (AHA) report. … [Read more...]

PhRMA: Strike 340B Data in Orphan Drug Case

 

PhRMA has asked a federal judge to strike a hospital survey from a friend-of-the court brief filed by 340B healthcare providers. … [Read more...]

Merck Announces 340B Refunds

Drugs Range from Remeron to Follistim 

Pharmaceutical manufacturer Merck Sharp & Dohme Corp. has announced it will give refunds to 340B providers that bought certain products between 2002 and 2013.   … [Read more...]

Hospitals Ask Court to Uphold Orphan Drug Rule

Support Broader Use Under 340B 

Organizations representing safety-net healthcare providers filed a friend-of-the-court brief Dec. 20 supporting a Department Health and Human Services (HHS) rule that allows many of their members to receive discounted pricing on “orphan” drugs when not used to treat rare diseases.   … [Read more...]

Orphan Drug Case Heats Up

Hospitals and other providers weighing in against PhRMA 

A flutter of briefs is landing at the U.S. District Court for the District of Columbia as hospitals square off against the pharmaceutical industry’s efforts to limit sales of discounted orphan drugs to 340B providers. … [Read more...]

340B Provider Audits from First Year Nearly Complete

Pedley gives program status report to stakeholders at Orlando meeting 

December 17, 2013—The federal office that oversees the 340B program "is close" to closing the last two audits of health care providers it conducted in fiscal year 2012, Office of Pharmacy Affairs (OPA) Director Cmdr. Krista Pedley told 340B stakeholders in Orlando last week. … [Read more...]

« Previous Page
Next Page »

LATEST ARTICLES DELIVERED

Get new article alerts via email.

This field is required.

Check your inbox or spam folder now to confirm your subscription.

FOLLOW | SHARE | LIKE

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

340B Health Twitter

Twitter feed is not available at the moment.

RSS 340B Employed

  • 340B Compliance Auditor | Geisinger April 3, 2026
  • Coordinator Pharmacy 340B Program - General Pharmacy - Full Time | CHRISTUS Health April 3, 2026
  • Pharmacy Business Manager | Nemours Children's Health April 3, 2026
  • 340B Director - Milwaukee, WI | Ascension March 24, 2026
  • Analyst, 340B Program | University of Texas Medical Branch March 5, 2026

Copyright © 2026 · 340B Health